PMC5505909_01
The clinical course of the low-density lipoprotein cholesterol (LDL-C) levels of a 76-year-old man with familial hypercholesterolemia (Case 1). The continuous line indicates the LDL-C values measured before and after each LDL apheresis session (LDL-A; full triangles). The patient was successfully weaned from LDL-A because his LDL-C levels remained low immediately after the initiation of evolocumab therapy (arrows).
1349-7235-56-1531-g001.jpg
PMC5505909_01_1349-7235-56-1531-g001.jpg
g001
Fig. 1 shows the evolution of the LDL-C levels, which remained below 100 mg/dL as soon as evolocumab therapy was initiated.
PMC5505909_02
The clinical course of the low-density lipoprotein cholesterol (LDL-C) levels of a 75-year-old woman with familial hypercholesterolemia (Case 2). The continuous line indicates the LDL-C values measured before and after each LDL apheresis session (LDL-A; full triangles). The patient was successfully weaned from LDL-A because her LDL-C levels remained low immediately after the initiation of evolocumab therapy (arrows).
1349-7235-56-1531-g002.jpg
PMC5505909_02_1349-7235-56-1531-g002.jpg
g002
Fig. 2 shows the evolution of LDL-C levels, which remained below 100 mg/dL as soon as evolocumab therapy was initiated.